コンテンツへスキップ
Merck
  • Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection.

Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection.

Proceedings of the National Academy of Sciences of the United States of America (2015-03-17)
Chad J Roy, Robert N Brey, Nicholas J Mantis, Kelly Mapes, Iliodora V Pop, Laurentiu M Pop, Stephen Ruback, Stephanie Z Killeen, Lara Doyle-Meyers, Heather S Vinet-Oliphant, Peter J Didier, Ellen S Vitetta
要旨

Ricin toxin (RT) is the second most lethal toxin known; it has been designated by the CDC as a select agent. RT is made by the castor bean plant; an estimated 50,000 tons of RT are produced annually as a by-product of castor oil. RT has two subunits, a ribotoxic A chain (RTA) and galactose-binding B chain (RTB). RT binds to all mammalian cells and once internalized, a single RTA catalytically inactivates all of the ribosomes in a cell. Administered as an aerosol, RT causes rapid lung damage and fibrosis followed by death. There are no Food and Drug Administration-approved vaccines and treatments are only effective in the first few hours after exposure. We have developed a recombinant RTA vaccine that has two mutations V76M/Y80A (RiVax). The protein is expressed in Escherichia coli and is nontoxic and immunogenic in mice, rabbits, and humans. When vaccinated mice are challenged with injected, aerosolized, or orally administered (gavaged) RT, they are completely protected. We have now developed a thermostable, aluminum-adjuvant-containing formulation of RiVax and tested it in rhesus macaques. After three injections, the animals developed antibodies that completely protected them from a lethal dose of aerosolized RT. These antibodies neutralized RT and competed to varying degrees with a panel of neutralizing and nonneutralizing mouse monoclonal antibodies known to recognize specific epitopes on native RTA. The resulting antibody competition profile could represent an immunologic signature of protection. Importantly, the same signature was observed using sera from RiVax-immunized humans.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
グリセロール, ACS reagent, ≥99.5%
Sigma-Aldrich
グリセロール, for molecular biology, ≥99.0%
Sigma-Aldrich
グリセロール, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
グリセロール 溶液, 83.5-89.5% (T)
Sigma-Aldrich
グリセロール, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
グリセロール, BioUltra, for molecular biology, anhydrous, ≥99.5% (GC)
Sigma-Aldrich
3,3′,5,5′-テトラメチルベンジジン, ≥99%
Sigma-Aldrich
グリセロール, puriss., anhydrous, 99.0-101.0% (alkalimetric)
USP
グリセリン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
N,O-ビス(トリメチルシリル)アセトアミド, synthesis grade, ≥95%
Sigma-Aldrich
グリセロール, puriss. p.a., ACS reagent, anhydrous, dist., ≥99.5% (GC)
Sigma-Aldrich
グリセロール, FCC, FG
Sigma-Aldrich
3,3′,5,5′-テトラメチルベンジジン, ≥98% (TLC)
Sigma-Aldrich
グリセロール, ≥99.5%
Sigma-Aldrich
3,3′,5,5′-テトラメチルベンジジン, ≥98.0% (NT)
Sigma-Aldrich
3,3′,5,5′-テトラメチルベンジジン, tablet, 1 mg substrate per tablet
Sigma-Aldrich
グリセロール, BioXtra, ≥99% (GC)
Sigma-Aldrich
グリセロール, JIS special grade, ≥99.0%
Sigma-Aldrich
グリセロール, SAJ first grade, ≥98.0%
Sigma-Aldrich
グリセリン, meets USP testing specifications
Supelco
グリセリン, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
グリセロール 溶液, puriss., meets analytical specification of Ph. Eur., BP, 84-88%
Supelco
グリセロール, analytical standard
Sigma-Aldrich
グリセロール, tested according to Ph. Eur., anhydrous
Supelco
N,O-ビス(トリメチルシリル)アセトアミド, for GC derivatization, LiChropur, ≥98.5% (GC)
Supelco
3,3′,5,5′-テトラメチルベンジジン, standard for GC